$VMCA
Valuence Merger Corp I Stock $vmca

$vmca Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-K Financial Statement

#000149315224011830 Filed on March 29, 2024

Income Statement

Concept	2023 Q4	2023	2022
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$124.0K	$1.392M
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$124.0K	$1.392M	$2.617M
YoY Change	-89.33%	-46.8%	26252.17%
Operating Profit		-$1.392M	-$2.617M
YoY Change		-46.8%
Interest Expense	$904.6K	$6.164M	$3.247M
YoY Change	-52.34%	89.8%
% of Operating Profit
Other Income/Expense, Net		$6.164M	$3.247M
YoY Change		89.8%
Pretax Income	$780.6K	$4.771M	$630.6K
YoY Change	6.1%	656.66%	-6450.45%
Income Tax
% Of Pretax Income
Net Earnings	$780.6K	$4.771M	$630.6K
YoY Change	6.1%	656.65%	-6450.47%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share	$0.07	$0.26	$0.03
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept	2023 Q4	2023	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$684.8K	$684.8K	$319.2K
YoY Change	114.54%	114.54%	78.62%
Cash & Equivalents	$684.8K
Short-Term Investments
Other Short-Term Assets	$78.07K	$78.07K	$522.4K
YoY Change	-85.06%	-85.06%	14.38%
Inventory
Prepaid Expenses	$78.07K
Receivables
Other Receivables
Total Short-Term Assets	$762.9K	$762.9K	$841.7K
YoY Change	-9.36%	-9.36%	32.45%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$69.40M	$69.40M	$229.9M
YoY Change	-69.82%	-69.82%
Other Assets
YoY Change
Total Long-Term Assets	$69.40M	$69.40M	$229.9M
YoY Change	-69.82%	-69.82%
TOTAL ASSETS
Total Short-Term Assets	$762.9K	$762.9K	$841.7K
Total Long-Term Assets	$69.40M	$69.40M	$229.9M
Total Assets	$70.17M	$70.17M	$230.8M
YoY Change	-69.6%	-69.6%	36218.83%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.229M	$2.229M	$1.989M
YoY Change	12.02%	12.02%
Accrued Expenses	$0.00	$0.00	$70.00K
YoY Change	-100.0%	-100.0%	-78.13%
Deferred Revenue
YoY Change
Short-Term Debt	$2.264M	$2.264M	$0.00
YoY Change			-100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$4.691M	$4.691M	$2.258M
YoY Change	107.77%	107.77%	263.94%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$8.105M	$8.105M	$8.105M
YoY Change	0.0%	0.0%
Total Long-Term Liabilities	$8.105M	$8.105M	$8.105M
YoY Change	0.0%	0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.691M	$4.691M	$2.258M
Total Long-Term Liabilities	$8.105M	$8.105M	$8.105M
Total Liabilities	$12.80M	$12.80M	$10.36M
YoY Change	23.48%	23.48%	1570.45%
SHAREHOLDERS EQUITY
Retained Earnings	-$11.89M
YoY Change	24.91%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$57.37M	$57.37M	$220.4M
YoY Change
Total Liabilities & Shareholders Equity	$70.17M	$70.17M	$230.8M
YoY Change	-69.6%	-69.6%	36218.83%

Cashflow Statement

Concept	2023 Q4	2023	2022
OPERATING ACTIVITIES
Net Income	$780.6K	$4.771M	$630.6K
YoY Change	6.1%	656.65%	-6450.47%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$186.2K	-$708.5K	-$1.150M
YoY Change	29.27%	-38.37%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$560.0K	$166.7M	-$226.7M
YoY Change		-173.54%
Cash From Investing Activities	-$560.0K	$166.7M	-$226.7M
YoY Change		-173.54%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		-$167.8M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	806.2K	-165.6M	$228.0M
YoY Change		-172.65%	127484.14%
NET CHANGE
Cash From Operating Activities	-186.2K	-708.5K	-$1.150M
Cash From Investing Activities	-560.0K	166.7M	-$226.7M
Cash From Financing Activities	806.2K	-165.6M	$228.0M
Net Change In Cash	59.97K	365.6K	$140.5K
YoY Change	-141.63%	160.22%	-21.37%
FREE CASH FLOW
Cash From Operating Activities	-$186.2K	-$708.5K	-$1.150M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital		usd
CY2023Q4	us-gaap	Deferred Costs DeferredCosts		usd
CY2022Q4	us-gaap	Deferred Costs DeferredCosts		usd
CY2023Q4	VMCAU	Accrued Offering Costs Current AccruedOfferingCostsCurrent		usd
CY2022Q4	VMCAU	Working Capital Loans WorkingCapitalLoans		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital		usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation Forfeited StockIssuedDuringPeriodValueShareBasedCompensationForfeited		usd
CY2022	VMCAU	Proceeds From Cash Withdrawn From Trust Account In Connection With Redemption ProceedsFromCashWithdrawnFromTrustAccountInConnectionWithRedemption		usd
CY2023	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering		usd
CY2023	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement		usd
CY2023	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		usd
CY2023	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
CY2022	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
CY2022	VMCAU	Proceeds From Convertible Promissory Note Related Party ProceedsFromConvertiblePromissoryNoteRelatedParty		usd
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock		usd
CY2023	VMCAU	Offering Costs Included In Accrued Offering Costs OfferingCostsIncludedInAccruedOfferingCosts		usd
CY2023	VMCAU	Deferred Underwriting Fee Payable DeferredUnderwritingFeePayable		usd
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	4 Orinda Way
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 100D
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Orinda
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	94563
CY2023	dei	City Area Code CityAreaCode	(415)
CY2023	dei	Local Phone Number LocalPhoneNumber	340-0222
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	true
CY2023Q2	dei	Entity Public Float EntityPublicFloat	66516789.78	usd
CY2023	dei	Auditor Firm AuditorFirmId	100
CY2023	dei	Auditor Name AuditorName	WithumSmith+Brown, PC
CY2023	dei	Auditor Location AuditorLocation	New York, New York
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	684816	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	319201	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	78070	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	522444	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	762886	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	841645	usd
CY2023Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	69402338	usd
CY2022Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	229949989	usd
CY2023Q4	us-gaap	Assets Assets	70165224	usd
CY2022Q4	us-gaap	Assets Assets	230791634	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2228645	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1989469	usd
CY2022Q4	VMCAU	Accrued Offering Costs Current AccruedOfferingCostsCurrent	70000	usd
CY2023Q4	VMCAU	Working Capital Loans WorkingCapitalLoans	613207	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4691177	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2257853	usd
CY2023Q4	VMCAU	Deferred Underwriting Commissions Noncurrent DeferredUnderwritingCommissionsNoncurrent	8105480	usd
CY2022Q4	VMCAU	Deferred Underwriting Commissions Noncurrent DeferredUnderwritingCommissionsNoncurrent	8105480	usd
CY2023Q4	us-gaap	Liabilities Liabilities	12796658	usd
CY2022Q4	us-gaap	Liabilities Liabilities	10363333	usd
CY2023Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	69262338	usd
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	229949989	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-11894322	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-9522238	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-11893772	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-9521688	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	70165224	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	230791634	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1392083	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2616768	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-1392083	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-2616768	usd
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest	6163554	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	3247370	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	3247370	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-15070	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	10401993	usd
CY2022	VMCAU	Adjustments To Additional Paid In Capital Fair Value Of Public Warrants Net Of Transaction Costs AdjustmentsToAdditionalPaidInCapitalFairValueOfPublicWarrantsNetOfTransactionCosts	5942690	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	325177	usd
CY2022	VMCAU	Adjustments To Additional Paid In Capital Accretion Of Common Stock Subject To Redemption AdjustmentsToAdditionalPaidInCapitalAccretionOfCommonStockSubjectToRedemption	-26186866	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	630602	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-9521688	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-9521688	usd
CY2023	VMCAU	Adjustments To Additional Paid In Capital Accretion Of Common Stock Subject To Redemption AdjustmentsToAdditionalPaidInCapitalAccretionOfCommonStockSubjectToRedemption	-7143555	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	4771471	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-11893772	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-11893772	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	4771471	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	630602	usd
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest	6163554	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	3247370	usd
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-444374	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	522444	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	239176	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1989469	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-708533	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1149743	usd
CY2023	us-gaap	Payments To Acquire Restricted Investments PaymentsToAcquireRestrictedInvestments	1120000	usd
CY2022	us-gaap	Payments To Acquire Restricted Investments PaymentsToAcquireRestrictedInvestments	226702620	usd
CY2023	VMCAU	Proceeds From Cash Withdrawn From Trust Account In Connection With Redemption ProceedsFromCashWithdrawnFromTrustAccountInConnectionWithRedemption	167831206	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	166711206	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-226702620	usd
CY2022	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	218300626	usd
CY2022	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	10401993	usd
CY2022	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	198007	usd
CY2022	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	300000	usd
CY2023	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	1650941	usd
CY2023	VMCAU	Proceeds From Convertible Promissory Note Related Party ProceedsFromConvertiblePromissoryNoteRelatedParty	613207	usd
CY2023	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	70000	usd
CY2022	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	607760	usd
CY2023	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	167831206	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-165637058	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	227992866	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	365615	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	140503	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	319201	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	178698	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	684816	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	319201	usd
CY2022	VMCAU	Offering Costs Included In Accrued Offering Costs OfferingCostsIncludedInAccruedOfferingCosts	70000	usd
CY2022	VMCAU	Deferred Underwriting Fee Payable DeferredUnderwritingFeePayable	8105480	usd
CY2022Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	11.50
CY2022Q1	us-gaap	Deposits Deposits	20702619	usd
CY2022Q1	VMCAU	Deposits Per Unit DepositsPerUnit	10.30
CY2022Q1	VMCAU	Proceeds From Deposit In Trust Account ProceedsFromDepositInTrustAccount	226702619	usd
CY2023	VMCAU	Transaction Costs TransactionCosts	10718994	usd
CY2023	us-gaap	Other Underwriting Expense OtherUnderwritingExpense	4000000	usd
CY2023	us-gaap	Payments For Underwriting Expense PaymentsForUnderwritingExpense	2200996	usd
CY2023	VMCAU	Deferred Underwriting Fees DeferredUnderwritingFees	8105480	usd
CY2023Q4	us-gaap	Other Deferred Costs Net OtherDeferredCostsNet	814510	usd
CY2021Q4	us-gaap	Sponsor Fees SponsorFees	25000	usd
CY2021Q4	VMCAU	Sponsor Fees And Valuence Sharse SponsorFeesAndValuenceSharse	5502490	usd
CY2023Q4	VMCAU	Percentage Of Fair Market Value PercentageOfFairMarketValue	0.80	pure
CY2023Q4	VMCAU	Net Tangible Asset Threshold For Redeeming Public Shares NetTangibleAssetThresholdForRedeemingPublicShares	5000001	usd
CY2023Q4	VMCAU	Net Tangible Asset Threshold For Redeeming Public Shares NetTangibleAssetThresholdForRedeemingPublicShares	5000001	usd
CY2023	VMCAU	Business Combination Conditions BusinessCombinationConditions	In connection with the approval of an amendment to the Company’s memorandum and articles of association to extend the Initial Business Combination Period, the Sponsor or its designees is required deposit into the Trust Account as a loan (a “Contribution” and the Sponsor or its designee making such Contribution, a “Contributor”), with respect to the initial extension to the Extended Date, $420,000, and with respect to each subsequent extension to an Additional Extended Date, one business day following the public announcement by the Company disclosing that the Board of Directors has determined to extend the date by which the Company must consummate a business combination for an additional month, with respect to the extension to each such Additional Extended Date, an amount equal to $140,000, in accordance with the Combination Period (each date on which a Contribution is to be deposited into the Trust Account, a “Contribution Date”).
CY2023	us-gaap	Business Combination Consideration Transferred1 BusinessCombinationConsiderationTransferred1	420000	usd
CY2023	VMCAU	Payments For Additional Amount PaymentsForAdditionalAmount	140000	usd
CY2023Q4	us-gaap	Deposits Deposits	2940000	usd
CY2023Q2	VMCAU	Aggregate Market Value Of Warrants Minimum AggregateMarketValueOfWarrantsMinimum	1000000	usd
CY2024Q1	us-gaap	Interest Bearing Domestic Deposit Money Market InterestBearingDomesticDepositMoneyMarket	100000000000	usd
CY2023Q4	VMCAU	Public Shares Redeem Percentage PublicSharesRedeemPercentage	1	pure
CY2023Q3	VMCAU	Payments For Deposits Into Trust Account PaymentsForDepositsIntoTrustAccount	140000	usd
CY2023Q4	VMCAU	Payments For Deposits Into Trust Account PaymentsForDepositsIntoTrustAccount	140000	usd
CY2023Q4	VMCAU	Payments For Deposits Into Trust Account PaymentsForDepositsIntoTrustAccount	140000	usd
CY2023Q4	VMCAU	Payments For Deposits Into Trust Account PaymentsForDepositsIntoTrustAccount	140000	usd
CY2023Q4	VMCAU	Payments For Deposits Into Trust Account PaymentsForDepositsIntoTrustAccount	560000	usd
CY2023Q4	us-gaap	Share Price SharePrice	10.00
CY2023Q4	us-gaap	Cash Cash	684816	usd
CY2023Q4	VMCAU	Working Capital Deficit WorkingCapitalDeficit	3928292	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84E_eus-gaap--UseOfEstimates_zTPDh3A6PsJ7" style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86B_zUp5re8CGfM4">Use of Estimates</span></span></p> <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q4	us-gaap	Cash Cash	684816	usd
CY2022Q4	us-gaap	Cash Cash	319201	usd
CY2023Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2022	us-gaap	Proceeds From Other Equity ProceedsFromOtherEquity	220099630	usd
CY2022	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	5942690	usd
CY2022	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	-10393817	usd
CY2022	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	26186866	usd
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	229949989	usd
CY2023	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	167831206	usd
CY2023	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	7143555	usd
CY2023Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	69262338	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2023Q4	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	0	usd
CY2022Q4	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	0	usd
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_844_eus-gaap--ConcentrationRiskCreditRisk_zf8g7HQdfrh2" style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86B_z37CcJZ8N0Pb">Concentration of Credit Risk</span></span></p> <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $<span id="xdx_909_eus-gaap--CashFDICInsuredAmount_iI_c20231231_zgBjDgJ0xrnf" title="Federal deposit insurance corporation coverage limit">250,000</span>. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2021Q4	us-gaap	Sponsor Fees SponsorFees	25000	usd
CY2023	us-gaap	Related Party Transaction Description Of Transaction RelatedPartyTransactionDescriptionOfTransaction	(A) one year after the completion of a Business Combination and (B) subsequent to a Business Combination, (x) if the closing price of the Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share dividends, rights issuances, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, share exchange or other similar transaction that results in all of the Public Shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property.
CY2023	us-gaap	Payments To Fund Longterm Loans To Related Parties PaymentsToFundLongtermLoansToRelatedParties	1500000	usd
CY2022Q1	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	198384	usd
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.01
CY2023Q4	VMCAU	Equity Proceeds Percentage EquityProceedsPercentage	0.60	pure
CY2023	us-gaap	Sale Of Stock Description Of Transaction SaleOfStockDescriptionOfTransaction	the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, the $18.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price, and the $10.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to the higher of the Market Value and the Newly Issued Price.
	VMCAU	Payments For Deposits Into Trust Account PaymentsForDepositsIntoTrustAccount	980000	usd

Files In Submission

Name	View Source	Status
0001493152-24-011830-index-headers.html	Edgar Link	pending
0001493152-24-011830-index.html	Edgar Link	pending
0001493152-24-011830.txt	Edgar Link	pending
0001493152-24-011830-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
ex97-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-k.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
form10-k_htm.xml	Edgar Link	completed
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
vmcau-20231231.xsd	Edgar Link	pending
vmcau-20231231_def.xml	Edgar Link	unprocessable
vmcau-20231231_lab.xml	Edgar Link	unprocessable
vmcau-20231231_pre.xml	Edgar Link	unprocessable
vmcau-20231231_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$VMCA
Valuence Merger Corp I Stock $vmca

2023 Q4 Form 10-K Financial Statement

#000149315224011830 Filed on March 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VMCA Valuence Merger Corp I Stock $vmca

2023 Q4 Form 10-K Financial Statement

#000149315224011830 Filed on March 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VMCA
Valuence Merger Corp I Stock $vmca